Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › genistein

genistein

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of genistein

6 trials tracked of genistein: 1 in phase 3 or 4.

6Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 5
  1. Phase 3 Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease Completed
  2. Phase 2 Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer Completed
  3. Phase 2 Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer Completed
  4. Phase 2 Genistein in Treatment of Metastatic Colorectal Cancer Completed
  5. Phase 2 Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer Completed
  6. Phase 2 Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Genistein shows potential to attenuate inflammation and reduce disease severity in autoimmune conditions
Allergy & Immunology Sys. Review
Genistein shows potential to attenuate inflammation and reduce disease severity in autoimmune conditions Genistein may help reduce inflammation in several autoimmune diseases
This mini review synthesizes preclinical evidence on genistein for autoimmune diseases including SLE, RA, and type 1 diabetes. Findings sugg…
A review of genistein shows it could lower disease severity and inflammation for people with conditions like lupus and rheumatoid arthritis.
Frontiers Jul 6, 2026
Genistein potentially provides multi-organ protection against ischemia-reperfusion injury through multiple signaling pathways
Drug Pipeline Sys. Review
Genistein potentially provides multi-organ protection against ischemia-reperfusion injury through multiple signaling pathways Genistein shows potential to protect multiple organs from injury
This narrative review with systematic literature identification explores the role of genistein and its derivatives in preclinical models of …
Research in animal models suggests genistein may protect the brain, kidneys, liver, and intestines from damage caused by a lack of blood flo…
Frontiers Jun 20, 2026